Orthophonic and / or Proprioceptive Treatment of Developmental Dyslexia. (Pro-Pho-Dys)

March 16, 2020 updated by: Luc-Marie Virlet, Scalab CNRS 9193

Remédiation Orthophonique couplée à Une Prise en Charge Proprioceptive de la Dyslexie. Etude Comparative randomisée

To show the interest of the association of proprioceptive and orthophonic care of dyslexic children. The assumption is that proprioceptive support by correcting a centrally located spatial localization instability restores the ability to automate.

It allows a gain of effectiveness of the orthophonic remediation of the reading of dyslexic children.

Interventional comparative study over 9 months, of three modes of care: Speech-language, or proprioceptive, or combined (speech therapy or proprioceptive)

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haut De France
      • Villeneuve-d'Ascq, Haut De France, France, 59653
        • Scalab CNRS 9193

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Developmental dyslexia, (CIM-10)
  • Having benefited from 2 years of speech therapy.
  • Pathological reading delay of more than 24 months or -2 standard deviations.
  • Either in the course of orthophonic care, or having stopped any orthophonic care.

Exclusion Criteria:

  • Refractive correction above +/- 1.5 diopters.
  • Absence of binocular vision.
  • Amblyopia.
  • Convulsion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Speech therapy
Speech therapy adapted to the child,
Speech therapy adapted to the child, at least 25 sessions over 9 months.
Other Names:
  • Orthophonic treatment
Experimental: Combined Treatment
Association of speech therapy and proprioceptive treatment, adapted to the child.
Speech therapy adapted to the child, at least 25 sessions over 9 months.
Other Names:
  • Orthophonic treatment

Proprioceptive treatment adapted to the child.

This treatment aims to stabilize a central reference instability revealed to Maddox Postural by the use of neurosensory decoys::

  • Proprioceptive stimulation of oculomotor muscles (active prisms).
  • Oral somatosensory stimulation (ALPH).
  • Proprioceptive antigravity stimulation (proprioceptive sole).
  • Proprioceptive reprogramming exercise.

Following the teaching of the University Diploma: Perception-Action, Learning Disorders (University of Bourgogne, France)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline C index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Number of correctly read words (standard deviation)
Baseline, at nine months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline TL index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Reading time in second (TL) (standard deviation)
Baseline, at nine months
Change from baseline M index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Number of words read (M)(standard deviation)
Baseline, at nine months
Change from baseline E index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Number of errors (E)(standard deviation)
Baseline, at nine months
Change from baseline CM index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Precision index (CM)(standard deviation)
Baseline, at nine months
Change from baseline CTL index ( Alouatte-R test) at 9 months
Time Frame: Baseline, at nine months
Speed index (CTL)(standard deviation)
Baseline, at nine months
Change from baseline Regular ODEDYS test at 9 months
Time Frame: Baseline, at nine months
Regular words reading, Screening tools for dyslexia (ODEDYS)(standard deviation)
Baseline, at nine months
Change from baseline Irregular ODEDYS test at 9 months
Time Frame: Baseline, at nine months
Irregular words reading (standard deviation)
Baseline, at nine months
change from baseline Pseudo-words ODEDYS test at 9 months
Time Frame: Baseline, at nine months
Pseudo-words reading (standard deviation)
Baseline, at nine months
Change from base line DFF VOG at 9 months
Time Frame: Baseline, at nine months
Duration of first fixation (DFF), of the measured reading in Video Oculography (VOG),
Baseline, at nine months
Change from baseline DL VOG at 9 months
Time Frame: Baseline, at nine months
Duration of look (DL), of the measured reading in Video Oculography (VOG),
Baseline, at nine months
Change from baseline TFT VOG at 9 months
Time Frame: Baseline, at nine months
Total fixation time (TFT), of the measured reading in Video Oculography (VOG),
Baseline, at nine months
Observation of the evolution of the shape of maxwells spots from baseline at 9 months
Time Frame: Baseline, at nine months
From the shape of Maxwell's tasks to the fovea-scope
Baseline, at nine months
Vertical orthophoria
Time Frame: Baseline, at nine months
Comparison of the evolution of reading tests, taking into account the presence or absence of localization instability, whatever the treatment groups.
Baseline, at nine months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Laurent Sparrow, MCF, Scalab CNRS 9193, Lille University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2018

Primary Completion (Actual)

October 5, 2019

Study Completion (Anticipated)

October 10, 2020

Study Registration Dates

First Submitted

February 15, 2018

First Submitted That Met QC Criteria

February 21, 2018

First Posted (Actual)

February 28, 2018

Study Record Updates

Last Update Posted (Actual)

March 17, 2020

Last Update Submitted That Met QC Criteria

March 16, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Scalab 2015-024EL
  • ID RCB : 2015-A01792-47 (Other Identifier: ANSM, France)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Developmental Dyslexia

Clinical Trials on Speech Therapy

3
Subscribe